Misplaced Pages

Bleb (cell biology)

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
(Redirected from Blebbing) Bulge in the plasma membrane of a cell
This article is missing information about prokaryotic blebs under the heading "membrane vesicles" -- actin's generally not involved and there are three classes by taxonomy. See bacterial outer membrane vesicles, PMID 23123555 and PMID 31942073. Please expand the article to include this information. Further details may exist on the talk page. (September 2022)
During apoptosis, blebbing is the first phase (left) of cell disassembly.

In cell biology, a bleb (or snout) is a bulge of the plasma membrane of a cell, characterized by a spherical, "blister-like", bulky morphology. It is characterized by the decoupling of the cytoskeleton from the plasma membrane, degrading the internal structure of the cell, allowing the flexibility required for the cell to separate into individual bulges or pockets of the intercellular matrix. Most commonly, blebs are seen in apoptosis (programmed cell death), but they are also seen in other non-apoptotic functions, including apocrine secretion (cell secretion by disintegration of part of a cell). Blebbing, or zeiosis, is the formation of blebs.

Formation

Initiation and expansion

Bleb growth is driven by intracellular pressure (abnormal growth) generated in the cytoplasm when the actin cortex undergoes actomyosin contractions. The disruption of the membrane-actin cortex interactions are dependent on the activity of myosin-ATPase Bleb initiation is affected by three main factors: high intracellular pressure, decreased amounts of cortex-membrane linker proteins, and deterioration of the actin cortex. The integrity of the connection between the actin cortex and the membrane are dependent on how intact the cortex is and how many proteins link the two structures. When this integrity is compromised, the addition of pressure is able to make the membrane bulge out from the rest of the cell. The presence of only one or two of these factors is often not enough to drive bleb formation. Bleb formation has also been associated with increases in myosin contractility and local myosin activity increases.

Bleb formation can be initiated in two ways: 1) through local rupture of the cortex or 2) through local detachment of the cortex from the plasma membrane. This generates a weak spot through which the cytoplasm flows, leading to the expansion of the bulge of membrane by increasing the surface area through tearing of the membrane from the cortex, during which time, actin levels decrease. The cytoplasmic flow is driven by hydrostatic pressure inside the cell. Before the bleb is able to expand, pressure must build enough to reach a threshold. This threshold is the amount of pressure needed to overcome the resistance of the plasma membrane to deformation.

Artificial induction

Bleb formation has been artificially induced in multiple lab cell models using different methods. By inserting a micropipette into a cell, the cell can be aspirated rapidly until destruction of cortex-membrane bonds causes blebbing. Breakage of cortex-membrane bonds has also been caused by laser ablation and injection of an actin depolymerizing drug, which in both cases eventually led to blebbing of the cell membrane. Artificially increased levels of myosin contractility were also shown to induce blebbing in cells. Some viruses, such as the poxvirus Vaccinia, have been shown to induce blebbing in cells as they bind to surface proteins. Although the exact mechanism is not yet fully understood, this process is crucial to endocytosing the virion and subsequent infection.

Cellular function

Apoptotic function

Blebbing is one of the defined features of apoptosis. During apoptosis (programmed cell death), the cell's cytoskeleton breaks up and causes the membrane to bulge outward. These bulges may separate from the cell, taking a portion of cytoplasm with them, to become known as apoptotic blebs. Phagocytic cells eventually consume these fragments and the components are recycled.

Two types of blebs are recognized in apoptosis. Initially, small surface blebs are formed. During later stages, larger so-called dynamic blebs may appear, which may carry larger organelle fragments such as larger parts of the fragmented apoptotic cell nucleus.

Function in cell migration

Along with lamellipodia, blebs serve an important role in cell migration. Migrating cells are able to polarize the formation of blebs so blebbing only occurs on the leading edge of the cell. A 2D moving cell is able to use adhesive molecules to gain traction in its environment while blebs form at the leading edge. By forming a bleb, the center of mass of the cell shifts forward and an overall movement of cytoplasm is accomplished. Cells have also been known to accomplish 3D bleb-based movement through a process called chimneying. In this process, cells exert pressure on the top and bottom substrates by squeezing themselves, causing a bleb on the leading edge to grow and the cell to have a net movement forward.

Apocrine secretion

Apocrine secretion is the mode of secretion of exocrine glands wherein secretory cells accumulate material at their apical ends, and this material then buds off from the cells. In many aspects, it can be seen as apoptosis of part of a cell. The secretion process generally initiates with secretory granules accumulating in an apical bleb (also called "apical snout") of the cell, which subsequently disintegrates to release secretory granules into the lumen.

  • Apocrine secretion Apocrine secretion
  • Histology of apocrine cells, H&E stain. Histology of apocrine cells, H&E stain.

Miscellaneous functions

Blebbing also has important functions in other cellular processes, including cell locomotion, cell division, and physical or chemical stresses. Blebs have been seen in cultured cells in certain stages of the cell cycle. These blebs are used for cell locomotion in embryogenesis. The types of blebs vary greatly, including variations in bleb growth rates, size, contents, and actin content. It also plays an important role in all five varieties of necrosis, a generally detrimental process. However, cell organelles do not spread into necrotic blebs.

Inhibition

Chemical structure of blebbistatin

In 2004, a chemical known as blebbistatin was shown to inhibit the formation of blebs. This agent was discovered in a screen for small molecule inhibitors of nonmuscle myosin IIA. Blebbistatin allosterically inhibits myosin II by binding near the actin-binding site and ATP-binding site. This interaction stabilizes a form of myosin II that is not bound to actin, thus lowering the affinity of myosin with actin. By interfering with myosin function, blebbistatin alters the contractile forces that impinge on the cytoskeleton-membrane interface and prevents the build up of intracellular pressure needed for blebbing. Blebbistatin has been investigated for its potential medical uses to treat fibrosis, cancer, and nerve injury. However, blebbistatin is known to be cytotoxic, photosensitive, and fluorescent, leading to the development of new derivatives to solve these problems. Some notable derivatives include azidoblebbistatin, para-nitroblebbistatin, and para-aminoblebbistatin.

References

  1. Smith A, Parkes MA, Atkin-Smith GK, Tixeira R, Poon IK (2017). "Cell disassembly during apoptosis". WikiJournal of Medicine. 4 (1). doi:10.15347/wjm/2017.008.
  2. Ponuwei GA, Dash PR (2016-12-01). "Bleb Formation in Human Fibrosarcoma HT1080 Cancer Cell Line Is Positively Regulated by the Lipid Signalling Phospholipase D2 (PLD2)". Achievements in the Life Sciences. 10 (2): 125–135. doi:10.1016/j.als.2016.11.001. ISSN 2078-1520.
  3. ^ Tinevez JY, Schulze U, Salbreux G, Roensch J, Joanny JF, Paluch E (November 2009). "Role of cortical tension in bleb growth". Proceedings of the National Academy of Sciences of the United States of America. 106 (44): 18581–18586. Bibcode:2009PNAS..10618581T. doi:10.1073/pnas.0903353106. PMC 2765453. PMID 19846787.
  4. ^ Fackler OT, Grosse R (June 2008). "Cell motility through plasma membrane blebbing". The Journal of Cell Biology. 181 (6): 879–884. doi:10.1083/jcb.200802081. PMC 2426937. PMID 18541702.
  5. ^ Charras GT (September 2008). "A short history of blebbing". Journal of Microscopy. 231 (3): 466–478. doi:10.1111/j.1365-2818.2008.02059.x. PMID 18755002. S2CID 205341971.
  6. ^ Wickman GR, Julian L, Mardilovich K, Schumacher S, Munro J, Rath N, et al. (October 2013). "Blebs produced by actin-myosin contraction during apoptosis release damage-associated molecular pattern proteins before secondary necrosis occurs". Cell Death and Differentiation. 20 (10): 1293–1305. doi:10.1038/cdd.2013.69. PMC 3770329. PMID 23787996.
  7. ^ Charras G, Paluch E (September 2008). "Blebs lead the way: how to migrate without lamellipodia". Nature Reviews. Molecular Cell Biology. 9 (9): 730–736. doi:10.1038/nrm2453. PMID 18628785. S2CID 36022784.
  8. ^ Paluch EK, Raz E (October 2013). "The role and regulation of blebs in cell migration". Current Opinion in Cell Biology. Cell adhesion and migration. 25 (5): 582–590. doi:10.1016/j.ceb.2013.05.005. PMC 3989058. PMID 23786923.
  9. Charras G, Paluch E (September 2008). "Blebs lead the way: how to migrate without lamellipodia". Nature Reviews. Molecular Cell Biology. 9 (9): 730–736. doi:10.1038/nrm2453. PMID 18628785. S2CID 36022784.
  10. Charras GT, Yarrow JC, Horton MA, Mahadevan L, Mitchison TJ (May 2005). "Non-equilibration of hydrostatic pressure in blebbing cells". Nature. 435 (7040): 365–369. Bibcode:2005Natur.435..365C. doi:10.1038/nature03550. PMC 1564437. PMID 15902261.
  11. ^ Paluch EK, Raz E (October 2013). "The role and regulation of blebs in cell migration". Current Opinion in Cell Biology. Cell adhesion and migration. 25 (5): 582–590. doi:10.1016/j.ceb.2013.05.005. PMC 3989058. PMID 23786923.
  12. ^ Mercer J, Helenius A (April 2008). "Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells". Science. 320 (5875): 531–535. Bibcode:2008Sci...320..531M. doi:10.1126/science.1155164. PMID 18436786. S2CID 41898225.
  13. Vermeulen K, Van Bockstaele DR, Berneman ZN (October 2005). "Apoptosis: mechanisms and relevance in cancer". Annals of Hematology. 84 (10): 627–639. doi:10.1007/s00277-005-1065-x. PMID 16041532. S2CID 26936920.
  14. van der Pol E, Böing AN, Gool EL, Nieuwland R (January 2016). "Recent developments in the nomenclature, presence, isolation, detection and clinical impact of extracellular vesicles". Journal of Thrombosis and Haemostasis. 14 (1): 48–56. doi:10.1111/jth.13190. PMID 26564379.
  15. Tixeira R, Caruso S, Paone S, Baxter AA, Atkin-Smith GK, Hulett MD, Poon IK (March 2017). "Defining the morphologic features and products of cell disassembly during apoptosis". Apoptosis. 22 (3): 475–477. doi:10.1007/s10495-017-1345-7. PMID 28102458. S2CID 34648758.
  16. Barros LF, Kanaseki T, Sabirov R, Morishima S, Castro J, Bittner CX, et al. (June 2003). "Apoptotic and necrotic blebs in epithelial cells display similar neck diameters but different kinase dependency". Cell Death and Differentiation. 10 (6): 687–697. doi:10.1038/sj.cdd.4401236. PMID 12761577.
  17. Optopharma (2017-07-03), English: 2D structure of blebbistatin, retrieved 2021-11-23
  18. ^ Limouze J, Straight AF, Mitchison T, Sellers JR (2004). "Specificity of blebbistatin, an inhibitor of myosin II". Journal of Muscle Research and Cell Motility. 25 (4–5): 337–341. doi:10.1007/s10974-004-6060-7. PMID 15548862. S2CID 22355306.
  19. ^ Rauscher AÁ, Gyimesi M, Kovács M, Málnási-Csizmadia A (September 2018). "Targeting Myosin by Blebbistatin Derivatives: Optimization and Pharmacological Potential". Trends in Biochemical Sciences. 43 (9): 700–713. doi:10.1016/j.tibs.2018.06.006. PMID 30057142. S2CID 51864413.
  20. ^ Straight AF, Cheung A, Limouze J, Chen I, Westwood NJ, Sellers JR, Mitchison TJ (March 2003). "Dissecting temporal and spatial control of cytokinesis with a myosin II Inhibitor". Science. 299 (5613): 1743–1747. Bibcode:2003Sci...299.1743S. doi:10.1126/science.1081412. PMID 12637748. S2CID 38625401.
  21. ^ Kovács M, Tóth J, Hetényi C, Málnási-Csizmadia A, Sellers JR (August 2004). "Mechanism of blebbistatin inhibition of myosin II". The Journal of Biological Chemistry. 279 (34): 35557–35563. doi:10.1074/jbc.M405319200. hdl:10831/92817. PMID 15205456.

Further reading

External links

Categories: